InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Davis Todd C, Director. Officer active across 3 companies, notably Ligand Pharmaceuticals INC. Cumulatively, 10 disclosures have been logged. The latest transaction was disclosed on 10 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations10 total
01,004 shares0
Common Stock
SEC:0000886163-22-000082:0·
0252,207 shares0
Common Stock
SEC:0001103021-22-000066:0·
07,684 shares0
Common Stock
SEC:0001103021-22-000027:0·
07,684 shares0
Common Stock
SEC:0001103021-22-000027·
01,470 shares0
Common Stock
SEC:0001437749-21-029223·
01,470 shares0
Common Stock
SEC:0001437749-21-029223:0·
030,000 shares0
Common Stock
SEC:0001103021-21-000068·
030,000 shares0
Common Stock
SEC:0001103021-21-000068:0·
0630 shares0
Common Stock
SEC:0000886163-21-000092·
0630 shares0
Common Stock
SEC:0000886163-21-000092:0·
10 of 10 declarations
About Davis Todd C
Todd C. Davis is a Board Member of Ligand Pharmaceuticals Inc., BioDelivery Sciences International Inc., and Vaxart, Inc. He brings expertise in biopharmaceuticals and drug development. His role involves guiding the strategic initiatives of these innovative companies.
